![]() |
Name |
Pestalafuranone C
|
Molecular Formula | C11H16O3 | |
IUPAC Name* |
3-(3-oxobutyl)-4-propyl-2H-furan-5-one
|
|
SMILES |
CCCC1=C(COC1=O)CCC(=O)C
|
|
InChI |
InChI=1S/C11H16O3/c1-3-4-10-9(6-5-8(2)12)7-14-11(10)13/h3-7H2,1-2H3
|
|
InChIKey |
KWQXZFPKWWRJGW-UHFFFAOYSA-N
|
|
Synonyms |
Pestalafuranone C
|
|
CAS | NA | |
PubChem CID | 139585320 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Molecular Weight: | 196.24 | ALogp: | 1.0 |
HBD: | 0 | HBA: | 3 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 43.4 | Aromatic Rings: | 1 |
Heavy Atoms: | 14 | QED Weighted: | 0.635 |
Caco-2 Permeability: | -4.663 | MDCK Permeability: | 0.00002360 |
Pgp-inhibitor: | 0.008 | Pgp-substrate: | 0.024 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.024 |
30% Bioavailability (F30%): | 0.011 |
Blood-Brain-Barrier Penetration (BBB): | 0.429 | Plasma Protein Binding (PPB): | 94.31% |
Volume Distribution (VD): | 1.55 | Fu: | 5.22% |
CYP1A2-inhibitor: | 0.259 | CYP1A2-substrate: | 0.892 |
CYP2C19-inhibitor: | 0.04 | CYP2C19-substrate: | 0.062 |
CYP2C9-inhibitor: | 0.043 | CYP2C9-substrate: | 0.895 |
CYP2D6-inhibitor: | 0.117 | CYP2D6-substrate: | 0.886 |
CYP3A4-inhibitor: | 0.009 | CYP3A4-substrate: | 0.134 |
Clearance (CL): | 12.439 | Half-life (T1/2): | 0.916 |
hERG Blockers: | 0.008 | Human Hepatotoxicity (H-HT): | 0.17 |
Drug-inuced Liver Injury (DILI): | 0.047 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.199 | Maximum Recommended Daily Dose: | 0.078 |
Skin Sensitization: | 0.45 | Carcinogencity: | 0.871 |
Eye Corrosion: | 0.01 | Eye Irritation: | 0.136 |
Respiratory Toxicity: | 0.045 |